Clinical trial
OMEGA, A Randomized Trial of Local Ablative Therapy Vs. Conventional Treatment in Oligometastatic NSCLC
NCT03827577 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OMEGA, A Randomized Trial of Local Ablative Therapy Vs. Conventional Treatment in Oligometastatic NSCLC
- Lead sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 1, 2019
- Completion date
- September 30, 2022
- Enrollment
- 195 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.